...
首页> 外文期刊>Archivio Italiano di Urologia e Andrologia >Comparison of the patient’s satisfaction underwent penile prosthesis; Malleable versus Ambicor: Single center experience
【24h】

Comparison of the patient’s satisfaction underwent penile prosthesis; Malleable versus Ambicor: Single center experience

机译:患者满意度的比较接受了阴茎假体;可延展的与Ambicor:单一中心体验

获取原文

摘要

Objective: To compare the surgical results, complications, and satisfaction levels of patients who underwent malleable penile prosthesis implantation (MPPI) and Ambicor penile prosthesis implantation (APPI) Material and methods: One hundred forty two patients who underwent penile prosthesis implantation [MPPI (Promedon Tube?, Cordoba, Argentina): 81, and APPI (American Medical Systems, Minnesota, USA): 61] between 20132018 were evaluated retrospectively Patients’ age, body mass index, smoking history, etiological factors, modified “Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Questionnaire” scores, shortening of the penis, and complications were recorded Results: The patients who performed APPI implantation were younger (5627 ± 1081 vs 5147 ± 1179, p = 0009) The EDITS scores of 31(382%) patients who underwent MPPI and 44 (724%) patients who underwent APPI were available It was observed that the scores on the following questions were statistical significantly higher in the APPI group: “Overall, are you satisfied with your penile prosthesis?, How much of your expectations did penile prosthesis meet?, How often do you use your penile prosthesis?” (p = 005, p = 0048, p = 0038) No difference was observed between the groups in terms of the scores on the other three questions (p = 0447, p = 0326, p = 0365) A 613% of patients in MPPI (19/31) group, and 568% of patients in APPI (25/44) group stated penile shortening (p = 0417) Mean shortening was reported as 21 ± 045 cm, and 212 ± 052 cm, in MPPI and APPI groups, respectively (p = 090) Conclusion:It is remarkable that the patients who underwent APPI experienced higher satisfaction with their prosthesis Even though it has not been evidenced in the current literature data, patients who have had either MPPI or APPI should be informed about the risk of penile shortening.
机译:目的:比较手术结果,并发症和满足程度的患者,接受可延展的可延展性阴茎假体植入(MPPI)和Ambicor Pinoile假体植入(APPI)材料和方法:一百四十两名接受阴茎假体植入的患者[MPPI(Promedon Tube?,阿根廷):81和Appi(美国医疗系统,Minnesota,USA):61]在20132018之间评估了患者的年龄,体重指数,吸烟病史,病因因子,改性的“治疗勃起的勃起功能障碍库存满意(编辑)问卷“评分,阴茎缩短,并发症被记录结果:进行APPI植入的患者更年轻(5627±1081 Vs 5147±1179,p = 0009)31(382%)患者的编辑评分谁接受了MPPI和44名(724%)的患者,观察了以下问题的分数统计显着更高在Appi Group:“总体上,你对你的阴茎假肢感到满意吗?你的期望有多少元化阴茎假肢相遇?,你多久使用一次阴茎假肢?” (P = 005,P = 0048,P = 0038)在其他三个问题的分数方面,在组之间观察到群体之间的差异(P = 0447,P = 0326,P = 0365)613%的MPPI患者(19/31)组,568%的APPI(25/44)组陈述阴茎缩短(P = 0417)平均缩短报告为21±045厘米,212±052厘米,在MPPI和APPI组中,分别是(p = 090)结论:即使在目前的文献数据中没有被证明,接受了应用程序的患者,仍然对其假肢进行了更高的满足感,应当通知有MPPI或APPI的患者对风险的影响阴茎缩短。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号